EMA Accepts GSK's Filing for Expanded Use of RSV Vaccine Arexvy

• click to rate

  Posted by Two Blokes Jun 16 - Filed in Stock - 6 views
  
  GSK's regulatory filing for expanded use of RSV vaccine, Arexvy, in adults aged 18 years and older has been accepted for review by the EMA.